🔥【活动通知】:科研通第二届『应助活动周』重磅启航,3月24-30日求助秒级响应🚀,千元现金等你拿。这个春天,让互助之光璀璨绽放!查看详情

The use of Cochrane Reviews in NICE clinical guidelines

科克伦图书馆 梅德林 系统回顾 临床试验 奇纳 荟萃分析 心理干预 指南 随机对照试验 重症监护医学 循证医学 临床实习 临床疗效
作者
Phil Alderson,Toni Tan
出处
期刊:Cochrane Database of Systematic Reviews 被引量:9
标识
DOI:10.1002/14651858.ed000032
摘要

Dirk Wiersma/Science Photo Library The National Institute for Health and Clinical Excellence (NICE) produces clinical guidelines for the National Health Service (NHS) in England and Wales. These guidelines are developed by groups that combine people with expertise in conducting systematic reviews and health economic analyses, with those with expertise in the clinical area (from healthcare professionals and patients). During guideline development, the group poses about 20 to 25 clinical questions, which are then addressed by systematic reviews. As described in the NICE Guidelines Manual,[1] groups routinely search for existing relevant systematic reviews. The NHS funds NICE and makes substantial contributions to The Cochrane Collaboration, so there is a common interest in making the best use of Cochrane Reviews for informing guidelines. One way of assessing the extent to which systematic reviews are used in guidelines is to look at the number of citations of reviews in each guideline. In a recent piece of work, we aimed to find out the extent of citation of Cochrane Reviews in NICE guidelines. For all NICE guidelines published before the end of February 2011 we used full‐text searching of the full version of the guideline (and appendices) to identify the word ‘Cochrane’. Where the occurrence of ‘Cochrane’ was a citation of a Cochrane Review, we looked for the current version of the Cochrane Review (or the record of a withdrawn Cochrane Review) in the Cochrane Database of Systematic Reviews (CDSR); we then identified and assigned the name of the Cochrane Review Group (CRG) developing the Cochrane Review to each citation. We tried to examine the context of the use of the Cochrane Review, and decide whether it was used as a source of evidence or as a background document (for example, a review describing how an intervention has been used for a completely different condition). By the end of February 2011 NICE had published 116 clinical guidelines. Ten of these had been replaced by a more up‐to‐date version, leaving 106 guidelines in the sample. There were 731 citations of Cochrane Reviews in the 106 guidelines, ranging from no citations to 44 citations, with a mean of 6.90 (standard deviation 9.23). Some Cochrane Reviews were cited more than once in different guidelines; therefore, the figures do not represent the number of Cochrane Reviews cited. There were 23 citations that we judged to be for background use rather than directly used to address guideline questions, but we have included these in the data below, as it was difficult at times to be sure of this coding. Table 1 shows the frequency of citations in guidelines. Open in table viewerTable 1. Frequency distribution of Cochrane Review citations in NICE clinical guidelines Of the 52 currently registered CRGs, 46 had Cochrane Reviews cited. The maximum number of citations for any CRG was 192. Summary frequencies of citations for the CRGs are shown in Table 2. Open in table viewerTable 2. Frequency distribution of Cochrane Review citations by CRG The coding of Cochrane Reviews by CRG used the CRG listed in the latest version of the CDSR; if the Cochrane Review cited in the guideline was not in the latest version, we used the Cochrane Review with the most similar title to the citation. The citations in guidelines may be several years old, authors and titles of Cochrane Reviews change, and some Cochrane Reviews are allocated to new CRGs. Therefore, there may be some errors in these data, but it is likely these are only a small percentage. The data show that some CRGs do not have any Cochrane Reviews cited in NICE guidelines, which may be because they do not map clearly on to the topics covered to date in NICE clinical guidelines. More recently established CRGs would also have had less chance to both develop Cochrane Reviews and have them cited. Even with these limitations, the data show the extensive use of Cochrane Reviews in the development of NICE clinical guidelines. Preliminary work in analysing the types of questions posed in NICE guidelines suggests that around half of the questions concern interventions of the type addressed by most Cochrane Reviews, with a mean of about 14 intervention questions per guideline. Although the data show an impressive level of use of Cochrane Reviews in NICE clinical guidelines, there is no doubt that we could do more to make efficient use of Cochrane Reviews, and work together for mutual benefit in a number of ways. We could make better use of the knowledge contained in CRGs when we draw up the scope for guidelines, and encourage more involvement from Cochrane Review authors on NICE guideline development groups. We could do more to ensure that Cochrane Reviews and guideline questions are better aligned, work harder at sharing knowledge from Cochrane Reviews and guidelines in development, and try to speed up the editorial process of turning relevant Cochrane Protocols into Cochrane Reviews, or updates of Cochrane Reviews, so that they can be considered for a clinical guideline. As guideline developers, we need to ensure that appropriate credit is given when Cochrane Reviews are used, and we could be more active in giving constructive feedback to Cochrane Review authors. It is very difficult to convert non‐Cochrane Reviews into Cochrane Reviews, but perhaps we can work harder to make our different timelines and processes work together to reduce duplication of effort. Updating is a common challenge, and there must be some scope for sharing intelligence. This idea of working together is not new, and there have been a number of initiatives around particular clinical guidelines to make better use of Cochrane Reviews.[2, 3] Within England and Wales, there is an increasing appetite to try to make this relationship work better for mutual benefit. In September 2011, there will be a workshop between the clinical guidelines team at NICE and several people with various roles in The Cochrane Collaboration. Let's make this the start of a constructive dialogue to make sure all our efforts better inform clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
gtgyh完成签到 ,获得积分10
1秒前
orixero应助susu采纳,获得10
1秒前
suchashing发布了新的文献求助10
3秒前
方不可方可完成签到,获得积分10
8秒前
隐形曼青应助标致的问晴采纳,获得10
10秒前
14秒前
Kevin完成签到,获得积分10
15秒前
老阶梯完成签到,获得积分10
15秒前
15秒前
ding应助咳咳采纳,获得10
15秒前
16秒前
科研通AI5应助追寻的依柔采纳,获得10
17秒前
Karte发布了新的文献求助10
19秒前
智多鑫发布了新的文献求助10
19秒前
lango完成签到,获得积分10
19秒前
奥斯卡完成签到,获得积分0
20秒前
susu发布了新的文献求助10
22秒前
diu完成签到,获得积分10
22秒前
23秒前
今后应助阿拉拉采纳,获得10
24秒前
搞怪三颜关注了科研通微信公众号
25秒前
26秒前
王安妮完成签到,获得积分20
27秒前
28秒前
Akim应助智多鑫采纳,获得10
29秒前
30秒前
J卡卡K完成签到 ,获得积分10
32秒前
32秒前
气急败坏的卡尔王完成签到 ,获得积分10
33秒前
33秒前
科研通AI2S应助Haydeehu采纳,获得10
36秒前
lixl0725完成签到 ,获得积分10
36秒前
爱吃蛋饼的zach完成签到 ,获得积分10
36秒前
susu完成签到,获得积分10
37秒前
上善若水完成签到 ,获得积分10
37秒前
_十三发布了新的文献求助10
37秒前
37秒前
38秒前
TZ完成签到 ,获得积分10
38秒前
40秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Conference Record, IAS Annual Meeting 1977 1150
Structural Load Modelling and Combination for Performance and Safety Evaluation 1000
Neuromuscular and Electrodiagnostic Medicine Board Review 800
Teaching language in context (3rd edition) by Derewianka, Beverly; Jones, Pauline 610
EEG in clinical practice 2nd edition 1994 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3601623
求助须知:如何正确求助?哪些是违规求助? 3170207
关于积分的说明 9564527
捐赠科研通 2876376
什么是DOI,文献DOI怎么找? 1579415
邀请新用户注册赠送积分活动 742603
科研通“疑难数据库(出版商)”最低求助积分说明 725360